StockVS

NASDAQ · Pharmaceutical Retailers · USD

Ridgetech, Inc. (RDGT) Stock Analysis

Ridgetech, Inc. (RDGT) is a Pharmaceutical Retailers stock listed on NASDAQ and quoted in US Dollar.

RDGT

$0.91

+$0.01 (+1.11%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare RDGT with… →

RDGT Key Statistics

As of Sep 4, 2026
Trading
Open
$0.89
Previous Close
$0.90
Day's Range
0.89–0.95
52-Week Range
0.67–760.50
Volume
20.70K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
−0.09
Valuation
Market Cap
$3.30M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.02
EPS (ttm)Profit attributable to each share over the last twelve months.
−17.21
Financials (FY)
Revenue (FY)
$119.97M−3.24%
Net Income (FY)
$10.19M
Profit marginThe share of revenue left as profit after all costs and taxes.
−0.95%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
3.63M
1-Year Return
−99.57%
Dividend and dates
Avg Volume
4.12M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

RDGT Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−99.79%
2025+61.02%
2024−59.77%
2023−93.85%
2022−21.49%
2021−62.38%
2020−44.51%
2019−9.00%
2018+61.29%
2017−27.06%
2016 (partial year)−10.99%

As of September 4, 2026.

RDGT Revenue and Earnings by Fiscal Year

FY ends March
Fiscal yearRevenueNet incomeNet margin
2024$119.97M$10.19M8.5%
2023$123.99M−$4.23M−3.4%
2022$120.20M−$21.14M−17.6%
2021$164.39M−$3.19M−1.9%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2024$119.97M$3.84M−$1.04M$10.19M8.5%
2023$123.99M$4.88M$596.08K−$4.23M−3.4%
2022$120.20M$3.60M−$13.16M−$21.14M−17.6%
2021$164.39M$36.52M−$2.55M−$3.19M−1.9%

Annual figures as reported, in the company's reporting currency. As of March 31, 2025.

RDGT Valuation vs Pharmaceutical Retailers Median

Median of 6 stocks
MetricRDGTPharmaceutical Retailers medianvs median
P/S ratio0.020.340.1x the median
Profit margin−0.95%−11.95%11.0 pts above

Medians across 6 Pharmaceutical Retailers stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Ridgetech, Inc. (RDGT) is capitalised at $3.30M on the latest close. The company sits in the Healthcare sector, in the Pharmaceutical Retailers industry. Headcount on file is 64.

Over the past 52 weeks the price has ranged from $0.67 to $760.50. RDGT last closed at $0.91 on September 4, 2026. That is +$0.01 (+1.11%) against the previous close. The latest close sits 35.82% above that 52-week low.

Financial Health

In fiscal 2024, Ridgetech, Inc. reported revenue of $119.97M. Against the prior fiscal year total of $123.99M, that is a change of −3.24%. Net income for the same year was $10.19M. Profit margin runs at −0.95%. That is 11 percentage points above the Pharmaceutical Retailers median of −11.95%. Trailing earnings per share are −17.21.

Across the 4 fiscal years on file, revenue moves from $164.39M in 2021 to $119.97M in 2024. Of those 4 years, 1 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The price-to-sales ratio is 0.02. On price-to-sales that is 0.1 times the Pharmaceutical Retailers median of 0.34. The medians here are taken across 6 Pharmaceutical Retailers companies that report the metric.

Over the trailing twelve months the price has returned −99.57%. Across 10 years the annualized return works out at −67.55%. Beta against the wider market is reported at −0.09. Daily returns over the trailing 10 years annualize to a volatility of 114.52%.

Growth & Income

No dividend is on file for RDGT.

So far in 2026 the price is −99.79%. The strongest complete calendar year on file is 2018 at +61.29%; the weakest is 2023 at −93.85%. Of the 9 complete calendar years on file, 2 finished higher.

Peer Comparison

Ridgetech, Inc. (RDGT) operates in the Pharmaceutical Retailers industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Ridgetech, Inc. RDGT $3.30M
High Tide Inc. HITI $225.39M
TelyRx Holdings Inc. TELY.TO $65.15M
PetMed Express, Inc. PETS $39.24M

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Pharmaceutical Retailers Stocks

View all Pharmaceutical Retailers stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About Ridgetech, Inc.

Ridgetech, Inc. operates as a wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. It operates in two segments, Offline Wholesale and Online Platform. The company engages in the offline and online wholesale distribution of pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicine, personal and family care products, and medical devices, as well as convenience products comprising consumable, seasonal, and promotional items. It also distributes other healthcare products, such as health food, cosmetics, and daily necessities. The company was formerly known as China Jo-Jo Drugstores, Inc. and changed its name to Ridgetech, Inc. in February 2024. Ridgetech, Inc. is headquartered in Hangzhou, China.

Visit website →